Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by introduction of a novel coronavirus into humans in late 2019 in China’s Hubei...
Dr. Angela RasmussenWant to learn more about animal models for studying #SARSCoV2 #COVID19 #coronavirus? Just out: the @nature review I had the great privilege of contributing to with my wonderful colleagues on the @WHO Expert Committee on Preclinical COVID-19 Models.
Importance: Fatality rates related to COVID-19 in Japan have been low compared to Western Countries and have decreased despite the absence of lockdown. Serological tests monitored across the course of the second wave can provide insights into the...
Long before COVID brought mathematical models to the forefront of news sites worldwide, modelling was used extensively to inform policy for animal and human health. In this talk, Joaquin will briefly cover his latest work on informing the WHO...
Schedule of speakers:
9/24/20: Bonnielin Swenor, Director of the Johns Hopkins Disability Health Research Center and Associate Professor of Ophthalmology at the Johns Hopkins Bloomberg School of Public Health
10/1/20: Jarvis Chen, Research...
Anyone handicapping the so-called competition to develop vaccines would do well to keep an eye on the players who seemingly got a late start.
Helen BranswellA lot of attention is paid to the frontrunners in the #Covid19 vaccine race. But the US may end up licensing 5, 6, 7 or more Covid vaccines, providing that many work. And some of those currently near the back of the first pack may have some advantages.
Researchers hope to begin world’s first human challenge trials at east London quarantine facility in January
A Marm KilpatrickLots of discussion & opinions about human trials to test efficacy of vaccines. They provide key data to answer a Q that normal phase 3 trials can't:
Does the vaccine reduce infectiousness?
However, they have imp. limitations & carry risks.
Both travel experts and passengers are keen to get fast, reliable and affordable Covid-19 testing as soon as possible. Here's why it's not going to be an easy road.
CCDD at Harvard Chan"Diagnosing people doesn't do much to stop the outbreak. I want tests that will tell somebody that they're transmitting so they can act on it. If everyone who tests positive stayed home, we would break the transmission." @michaelmina_lab